{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:02:59Z","timestamp":1790834579842,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":1235,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008730","name":"Norwegian Cancer Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bbamcr.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,1,16]],"date-time":"2010-01-16T04:16:05Z","timestamp":1263615365000},"page":"386-395","source":"Crossref","is-referenced-by-count":22,"title":["Chk2 splice variants express a dominant-negative effect on the wild-type Chk2 kinase activity"],"prefix":"10.1016","volume":"1803","author":[{"given":"Elisabet Ognedal","family":"Berge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidar","family":"Staalesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Hege","family":"Straume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan Richard","family":"Lillehaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Eystein","family":"L\u00f8nning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2010.01.005_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biochem.72.121801.161720","article-title":"Mechanisms of alternative pre-messenger RNA splicing","volume":"72","author":"Black","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrm1645","article-title":"Understanding alternative splicing: towards a cellular code","volume":"6","author":"Matlin","year":"2005","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1242\/jcs.03053","article-title":"The connection between splicing and cancer","volume":"119","author":"Srebrow","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0168-9525(01)02626-9","article-title":"Alternative splicing: multiple control mechanisms and involvement in human disease","volume":"18","author":"Caceres","year":"2002","journal-title":"Trends Genet."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib6","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/gcc.20156","article-title":"Alterations of pre-mRNA splicing in cancer","volume":"42","author":"Kalnina","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1470-2045(07)70104-3","article-title":"Alternative splicing: an emerging topic in molecular and clinical oncology","volume":"8","author":"Pajares","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib8","doi-asserted-by":"crossref","first-page":"7647","DOI":"10.1158\/0008-5472.CAN-04-1910","article-title":"Aberrant and alternative splicing in cancer","volume":"64","author":"Venables","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/0008-5472.CAN-04-4249","article-title":"A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk","volume":"65","author":"Narla","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib10","first-page":"5934","article-title":"Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation","volume":"60","author":"Ahn","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib11","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/MCB.22.12.4419-4432.2002","article-title":"Chk2 activation and phosphorylation-dependent oligomerization","volume":"22","author":"Xu","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib12","doi-asserted-by":"crossref","first-page":"30537","DOI":"10.1074\/jbc.M104414200","article-title":"The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation","volume":"276","author":"Lee","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib13","first-page":"598","article-title":"Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation","volume":"1","author":"Schwarz","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/35071124","article-title":"The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis","volume":"410","author":"Falck","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-9822(99)80041-4","article-title":"A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase","volume":"9","author":"Blasina","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib16","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1126\/science.282.5395.1893","article-title":"Linkage of ATM to cell cycle regulation by the Chk2 protein kinase","volume":"282","author":"Matsuoka","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1101\/gad.14.3.289","article-title":"The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites","volume":"14","author":"Shieh","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib18","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","article-title":"Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage","volume":"96","author":"Chehab","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1101\/gad.14.3.278","article-title":"Chk2\/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53","volume":"14","author":"Chehab","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib20","doi-asserted-by":"crossref","first-page":"8535","DOI":"10.1038\/sj.onc.1207928","article-title":"Alternative splicing and mutation status of CHEK2 in stage III breast cancer","volume":"23","author":"Staalesen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib21","doi-asserted-by":"crossref","first-page":"e3062","DOI":"10.1371\/journal.pone.0003062","article-title":"CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancer","volume":"3","author":"Chrisanthar","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib22","first-page":"2505","article-title":"Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer","volume":"61","author":"Geisler","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib23","first-page":"5582","article-title":"TP53 gene mutations predict the response to neoadjuvant treatment with 5-fluorouracil and mitomycin in locally advanced breast cancer","volume":"9","author":"Geisler","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"20475","DOI":"10.1074\/jbc.M213159200","article-title":"The Chk2 tumor suppressor is not required for p53 responses in human cancer cells","volume":"278","author":"Jallepalli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/BJ20041071","article-title":"Identification and characterization of the human ARD1-NATH protein acetyltransferase complex","volume":"386","author":"Arnesen","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/BJ20080658","article-title":"Identification of the human N(alpha)-acetyltransferase complex B (hNatB): a complex important for cell-cycle progression","volume":"415","author":"Starheim","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/sj.onc.1204161","article-title":"Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas","volume":"20","author":"Fluge","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib28","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1038\/sj.onc.1204811","article-title":"Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway","volume":"20","author":"Falck","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib29","doi-asserted-by":"crossref","first-page":"42346","DOI":"10.1074\/jbc.M303304200","article-title":"Karyopherin-alpha2 protein interacts with Chk2 and contributes to its nuclear import","volume":"278","author":"Zannini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"36163","DOI":"10.1074\/jbc.M303795200","article-title":"Autophosphorylation of checkpoint kinase 2 at serine 516 is required for radiation-induced apoptosis","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib31","doi-asserted-by":"crossref","first-page":"19389","DOI":"10.1074\/jbc.M200822200","article-title":"Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain","volume":"277","author":"Ahn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib32","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1038\/sj.emboj.7601209","article-title":"Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange","volume":"25","author":"Oliver","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib33","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1126\/science.286.5449.2528","article-title":"Heterozygous germ line hCHK2 mutations in Li\u2013Fraumeni syndrome","volume":"286","author":"Bell","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/jmg.38.4.253","article-title":"Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li\u2013Fraumeni or Li\u2013Fraumeni-like syndrome","volume":"38","author":"Bougeard","year":"2001","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jmg.2007.054700","article-title":"Is CHEK2 a cause of the Li\u2013Fraumeni syndrome?","volume":"45","author":"Evans","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/jmg.2007.054494","article-title":"BRCA2: a cause of Li\u2013Fraumeni-like syndrome","volume":"45","author":"Evans","year":"2008","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10689-004-1946-5","article-title":"The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li\u2013Fraumeni-like kindreds","volume":"4","author":"Siddiqui","year":"2005","journal-title":"Fam. Cancer"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.10136","article-title":"Increasing evidence that germline mutations in CHEK2 do not cause Li\u2013Fraumeni syndrome","volume":"20","author":"Sodha","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.289.5478.359a","article-title":"Screening hCHK2 for mutations","volume":"289","author":"Sodha","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib40","first-page":"5718","article-title":"p53, CHK2, and CHK1 genes in Finnish families with Li\u2013Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition","volume":"61","author":"Vahteristo","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib41","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1038\/sj.onc.1209877","article-title":"The CHEK2 gene and inherited breast cancer susceptibility","volume":"25","author":"Nevanlinna","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26, 000 patient cases and 27, 000 controls","volume":"26","author":"Weischer","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.20299","article-title":"CHEK2 variant I157T may be associated with increased breast cancer risk","volume":"111","author":"Kilpivaara","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib44","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ijc.21022","article-title":"Association of two mutations in the CHEK2 gene with breast cancer","volume":"116","author":"Bogdanova","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/426403","article-title":"CHEK2 is a multiorgan cancer susceptibility gene","volume":"75","author":"Cybulski","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-006-9320-y","article-title":"A deletion in CHEK2 of 5, 395bp predisposes to breast cancer in Poland","volume":"102","author":"Cybulski","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib47","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jama.295.12.1379","article-title":"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer","volume":"295","author":"Walsh","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/ddi052","article-title":"Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population","volume":"14","author":"Shaag","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib49","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.onc.1205207","article-title":"Concomitant inactivation of p53 and Chk2 in breast cancer","volume":"21","author":"Sullivan","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib50","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1158\/1078-0432.CCR-06-1770","article-title":"Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers","volume":"12","author":"Williams","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-4598-6-31","article-title":"LEDGF\/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro","volume":"6","author":"Huang","year":"2007","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbrc.2005.04.114","article-title":"RIP3 beta and RIP3 gamma, two novel splice variants of receptor-interacting protein 3 (RIP3), downregulate RIP3-induced apoptosis","volume":"332","author":"Yang","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib53","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma","volume":"62","author":"van Doorn","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib54","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/35103059","article-title":"CHK2 kinase\u2014a busy messenger","volume":"2","author":"Bartek","year":"2001","journal-title":"Nat. Rev., Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib55","doi-asserted-by":"crossref","first-page":"48418","DOI":"10.1074\/jbc.M208321200","article-title":"Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation","volume":"277","author":"Ahn","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/gcc.1207","article-title":"Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors","volume":"33","author":"Miller","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bbamcr.2010.01.005_bib57","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/bcr435","article-title":"Mutation analysis of the CHK2 gene in breast carcinoma and other cancers","volume":"4","author":"Ingvarsson","year":"2002","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.bbamcr.2010.01.005_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cells"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488910000066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488910000066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T12:18:35Z","timestamp":1685362715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488910000066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0167488910000066"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2010.01.005","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}